2024 Q4 Form 10-Q Financial Statement

#000149315224045956 Filed on November 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $127.4K
YoY Change -32.93%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $127.4K
YoY Change -32.93%
Operating Profit -$127.4K
YoY Change -32.01%
Interest Expense $952.8K
YoY Change 25.37%
% of Operating Profit
Other Income/Expense, Net $952.8K
YoY Change 25.22%
Pretax Income $825.4K
YoY Change 44.8%
Income Tax
% Of Pretax Income
Net Earnings $825.4K
YoY Change 43.93%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.09
COMMON SHARES
Basic Shares Outstanding 9.167M shares 9.167M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $271.9K
YoY Change -45.63%
Cash & Equivalents $271.8K
Short-Term Investments
Other Short-Term Assets $25.15K
YoY Change -79.04%
Inventory
Prepaid Expenses $25.15K
Receivables
Other Receivables
Total Short-Term Assets $297.0K
YoY Change -52.24%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $74.24M
YoY Change 5.38%
Other Assets
YoY Change
Total Long-Term Assets $74.24M
YoY Change 5.37%
TOTAL ASSETS
Total Short-Term Assets $297.0K
Total Long-Term Assets $74.24M
Total Assets $74.53M
YoY Change 4.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $209.1K
YoY Change 131.64%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $284.1K
YoY Change 214.72%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $284.1K
Total Long-Term Liabilities $0.00
Total Liabilities $284.1K
YoY Change 214.72%
SHAREHOLDERS EQUITY
Retained Earnings $12.65K
YoY Change -97.62%
Common Stock $227.00
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $12.88K
YoY Change
Total Liabilities & Shareholders Equity $74.53M
YoY Change 4.87%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income $825.4K
YoY Change 43.93%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$790.00
YoY Change -99.64%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -790.0
Cash From Investing Activities
Cash From Financing Activities 0.000
Net Change In Cash -790.0
YoY Change -100.16%
FREE CASH FLOW
Cash From Operating Activities -$790.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
Bowen Acquisition Corp
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
dei Entity Address Address Line1
EntityAddressAddressLine1
420 Lexington Ave
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 2446
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10170
dei City Area Code
CityAreaCode
(203)
dei Local Phone Number
LocalPhoneNumber
998-5540
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
402534 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001973056
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Entity File Number
EntityFileNumber
001-41741
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
9166500 shares
CY2024Q3 us-gaap Cash
Cash
271847 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
25152 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
284120 usd
CY2024Q3 us-gaap Liabilities
Liabilities
284120 usd
CY2024Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
74237487 usd
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
227 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
12652 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
12879 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
74534486 usd
CY2024Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
127429 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
786362 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
265404 usd
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
79481 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
103860 usd
CY2023Q4 us-gaap Liabilities
Liabilities
103860 usd
CY2023Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
71419358 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
402307 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
402534 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
71925752 usd
CY2023Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
187428 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
190533 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-187428 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-190533 usd
CY2023Q3 BOWN Interest Earned On Investments Held In Trust Account
InterestEarnedOnInvestmentsHeldInTrustAccount
760871 usd
BOWN Interest Earned On Investments Held In Trust Account
InterestEarnedOnInvestmentsHeldInTrustAccount
760871 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
760871 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
760871 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
573444 usd
us-gaap Net Income Loss
NetIncomeLoss
570338 usd
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q4 BOWN Payable To Target
PayableToTarget
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
usd
us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
BOWN Proceeds From Issuance Of Founder Shares
ProceedsFromIssuanceOfFounderShares
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
usd
BOWN Payments Of Underwriters Discount
PaymentsOfUnderwritersDiscount
usd
BOWN Proceeds From Private Placement
ProceedsFromPrivatePlacement
usd
BOWN Payment Of Offering Costs
PaymentOfOfferingCosts
usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
BOWN Offering Cost Paid By Target Company
OfferingCostPaidByTargetCompany
usd
BOWN Noncash Offering Costs Paid By Sponsor In Exchange For Issuance Of Ordinary Shares
NoncashOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares
usd
BOWN Noncash Offering Costs Adjusted From Prepaid Expenses
NoncashOfferingCostsAdjustedFromPrepaidExpenses
usd
BOWN Non Cash Offering Costs Charged To Additional Paidin Capital
NonCashOfferingCostsChargedToAdditionalPaidinCapital
usd
BOWN Reclassification Of Ordinary Shares Subject To Redemption
ReclassificationOfOrdinarySharesSubjectToRedemption
usd
BOWN Allocation Of Offering Costs To Ordinary Shares Subject To Redemption
AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption
usd
BOWN Remeasurement Adjustment On Ordinary Shares Subject To Possible Redemption
RemeasurementAdjustmentOnOrdinarySharesSubjectToPossibleRedemption
usd
CY2024Q3 BOWN Accretion Of Temporary Equity Into Redemption Value
AccretionOfTemporaryEquityIntoRedemptionValue
usd
BOWN Accretion Of Temporary Equity Into Redemption Value
AccretionOfTemporaryEquityIntoRedemptionValue
usd
dei Entity Listing Par Value Per Share
EntityListingParValuePerShare
0.0001
CY2023Q4 us-gaap Cash
Cash
426913 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
296999 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
506394 usd
CY2024Q3 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
74237487 usd
CY2023Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
71419358 usd
CY2024Q3 us-gaap Assets
Assets
74534486 usd
CY2023Q4 us-gaap Assets
Assets
71925752 usd
CY2024Q3 BOWN Payable To Target
PayableToTarget
75000 usd
CY2024Q3 BOWN Ordinary Shares Subject To Redemption
OrdinarySharesSubjectToRedemption
6900000 shares
CY2023Q4 BOWN Ordinary Shares Subject To Redemption
OrdinarySharesSubjectToRedemption
6900000 shares
CY2024Q3 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
10.76
CY2023Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
10.35
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2266500 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2266500 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2266500 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2266500 shares
CY2024Q3 BOWN Ordinary Shares Subject To Redemption
OrdinarySharesSubjectToRedemption
6900000 shares
CY2023Q4 BOWN Ordinary Shares Subject To Redemption
OrdinarySharesSubjectToRedemption
6900000 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
227 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
389655 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-127429 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-389655 usd
CY2024Q3 BOWN Interest Earned On Investments Held In Trust Account
InterestEarnedOnInvestmentsHeldInTrustAccount
952787 usd
BOWN Interest Earned On Investments Held In Trust Account
InterestEarnedOnInvestmentsHeldInTrustAccount
2818129 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
952787 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2818129 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
825358 usd
us-gaap Net Income Loss
NetIncomeLoss
2428474 usd
CY2024Q1 BOWN Subsequent Measurement Of Common Stock Subject To Possible Redemption Interest Earned On Trust Account
SubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionInterestEarnedOnTrustAccount
-923492 usd
CY2024Q2 BOWN Subsequent Measurement Of Common Stock Subject To Possible Redemption Interest Earned On Trust Account
SubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionInterestEarnedOnTrustAccount
-941850 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
816754 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
140308 usd
CY2024Q3 BOWN Subsequent Measurement Of Common Stock Subject To Possible Redemption Interest Earned On Trust Account
SubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionInterestEarnedOnTrustAccount
-952787 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
825358 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
12879 usd
CY2023Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
25000 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1016000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-3105 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-3105 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1037895 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1037895 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1037895 usd
CY2023Q3 BOWN Stock Issued During Period Value Proceeds From Sale Of Public Units
StockIssuedDuringPeriodValueProceedsFromSaleOfPublicUnits
60000000 usd
CY2023Q3 BOWN Stock Issued During Period Value Proceeds From Overallotment
StockIssuedDuringPeriodValueProceedsFromOverallotment
9000000 usd
CY2023Q3 BOWN Stock Issued During Period Value Sale Of Private Units
StockIssuedDuringPeriodValueSaleOfPrivateUnits
3300000 usd
CY2023Q3 BOWN Stock Issued During Period Value Overallotment Of Private Units
StockIssuedDuringPeriodValueOverallotmentOfPrivateUnits
315000 usd
CY2023Q3 BOWN Adjustments To Additional Paid In Capital Underwriters Commission On Sale Of Public Units
AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnSaleOfPublicUnits
-1500000 usd
CY2023Q3 BOWN Adjustments To Additional Paid In Capital Underwriters Commission On Overallotment
AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnOverallotment
-225000 usd
CY2023Q3 BOWN Adjustments To Additional Paid In Capital Other Offering Costs
AdjustmentsToAdditionalPaidInCapitalOtherOfferingCosts
-1518898 usd
CY2023Q3 BOWN Stock Issued During Period Value Initial Measurement Of Ordinary Shares
StockIssuedDuringPeriodValueInitialMeasurementOfOrdinaryShares
-65236367 usd
CY2023Q3 BOWN Adjustments To Additional Paid In Capital Allocation Of Offering Costs To Ordinary Shares Subject To Redemption
AdjustmentsToAdditionalPaidInCapitalAllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption
3066958 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock
AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock
-7520591 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-760871 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
573444 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
573444 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
531570 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
531570 usd
us-gaap Net Income Loss
NetIncomeLoss
2428474 usd
us-gaap Net Income Loss
NetIncomeLoss
570338 usd
BOWN Interest Earned On Investments Held In Trust Account
InterestEarnedOnInvestmentsHeldInTrustAccount
2818129 usd
BOWN Interest Earned On Investments Held In Trust Account
InterestEarnedOnInvestmentsHeldInTrustAccount
760871 usd
BOWN Increase Decrease In Accrued Offering Costs And Expenses
IncreaseDecreaseInAccruedOfferingCostsAndExpenses
160094 usd
BOWN Increase Decrease In Accrued Offering Costs And Expenses
IncreaseDecreaseInAccruedOfferingCostsAndExpenses
93383 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
40445 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-34050 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
120720 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-155066 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-217870 usd
us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
69690000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-69690000 usd
BOWN Proceeds From Issuance Of Founder Shares
ProceedsFromIssuanceOfFounderShares
2520 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
69000000 usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
3615000 usd
BOWN Payments Of Underwriters Discount
PaymentsOfUnderwritersDiscount
1725000 usd
BOWN Proceeds From Private Placement
ProceedsFromPrivatePlacement
-151318 usd
BOWN Payment Of Offering Costs
PaymentOfOfferingCosts
332204 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
70408998 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-155066 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
501128 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
426913 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
271847 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
501128 usd
BOWN Subsequent Measurement Of Ordinary Shares Subject To Possible Redemption
SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption
2818129 usd
BOWN Subsequent Measurement Of Ordinary Shares Subject To Possible Redemption
SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption
760871 usd
BOWN Offering Cost Paid By Target Company
OfferingCostPaidByTargetCompany
75000 usd
BOWN Noncash Offering Costs Paid By Sponsor In Exchange For Issuance Of Ordinary Shares
NoncashOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares
25000 usd
BOWN Noncash Offering Costs Adjusted From Prepaid Expenses
NoncashOfferingCostsAdjustedFromPrepaidExpenses
894 usd
BOWN Non Cash Offering Costs Charged To Additional Paidin Capital
NonCashOfferingCostsChargedToAdditionalPaidinCapital
1518898 usd
BOWN Reclassification Of Ordinary Shares Subject To Redemption
ReclassificationOfOrdinarySharesSubjectToRedemption
65236367 usd
BOWN Allocation Of Offering Costs To Ordinary Shares Subject To Redemption
AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption
3066958 usd
BOWN Remeasurement Adjustment On Ordinary Shares Subject To Possible Redemption
RemeasurementAdjustmentOnOrdinarySharesSubjectToPossibleRedemption
7520591 usd
CY2024Q3 us-gaap Cash
Cash
271847 usd
CY2024Q3 BOWN Working Capital Deficit
WorkingCapitalDeficit
12879 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_844_eus-gaap--UseOfEstimates_zWmafGCKWf6g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_zQn6z7kMJgn2">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the consolidated financial statement in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q3 us-gaap Cash
Cash
271847 usd
CY2023Q4 us-gaap Cash
Cash
426913 usd
CY2024Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2024Q3 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
74237487 usd
CY2023Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
71419358 usd
CY2024Q3 BOWN Interest Earned On Investments Held In Trust Account
InterestEarnedOnInvestmentsHeldInTrustAccount
952787 usd
BOWN Interest Earned On Investments Held In Trust Account
InterestEarnedOnInvestmentsHeldInTrustAccount
2818129 usd
CY2024Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2024Q3 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0 usd
CY2023Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
825358 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
573444 usd
us-gaap Net Income Loss
NetIncomeLoss
2428474 usd
us-gaap Net Income Loss
NetIncomeLoss
570338 usd
CY2024Q3 BOWN Accretion Of Temporary Equity Into Redemption Value Interest Earned
AccretionOfTemporaryEquityIntoRedemptionValueInterestEarned
952787 usd
CY2023Q3 BOWN Accretion Of Temporary Equity Into Redemption Value Interest Earned
AccretionOfTemporaryEquityIntoRedemptionValueInterestEarned
760871 usd
BOWN Accretion Of Temporary Equity Into Redemption Value Interest Earned
AccretionOfTemporaryEquityIntoRedemptionValueInterestEarned
2818129 usd
BOWN Accretion Of Temporary Equity Into Redemption Value Interest Earned
AccretionOfTemporaryEquityIntoRedemptionValueInterestEarned
760871 usd
CY2023Q3 BOWN Accretion Of Temporary Equity Into Redemption Value
AccretionOfTemporaryEquityIntoRedemptionValue
7520591 usd
BOWN Accretion Of Temporary Equity Into Redemption Value
AccretionOfTemporaryEquityIntoRedemptionValue
7520591 usd
CY2024Q3 BOWN Net Loss Including Accretion Of Equity Into Redemption Value
NetLossIncludingAccretionOfEquityIntoRedemptionValue
-127429 usd
CY2023Q3 BOWN Net Loss Including Accretion Of Equity Into Redemption Value
NetLossIncludingAccretionOfEquityIntoRedemptionValue
-7708018 usd
BOWN Net Loss Including Accretion Of Equity Into Redemption Value
NetLossIncludingAccretionOfEquityIntoRedemptionValue
-389655 usd
BOWN Net Loss Including Accretion Of Equity Into Redemption Value
NetLossIncludingAccretionOfEquityIntoRedemptionValue
-7711124 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_845_eus-gaap--ConcentrationRiskCreditRisk_zYzBp13LZLRg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_864_z73ZPC9Ej5Gh">Concentration of Credit Risk</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $<span id="xdx_905_eus-gaap--CashFDICInsuredAmount_iI_c20240930_zuExcTvHBmg" title="Cash FDIC insured amount">250,000</span>. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2023Q4 us-gaap Redeemable Noncontrolling Interest Equity Common Carrying Amount
RedeemableNoncontrollingInterestEquityCommonCarryingAmount
71419358 usd
BOWN Subsequent Measurement Of Ordinary Shares Subject To Possible Redemption
SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption
2818129 usd
CY2024Q3 us-gaap Redeemable Noncontrolling Interest Equity Common Carrying Amount
RedeemableNoncontrollingInterestEquityCommonCarryingAmount
74237487 usd
us-gaap Payments For Fees
PaymentsForFees
75000 usd
CY2023Q1 BOWN Equity Securities Fv Ni Term
EquitySecuritiesFvNiTerm
P1Y10M2D
CY2024Q3 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
30000 usd
us-gaap Administrative Fees Expense
AdministrativeFeesExpense
90000 usd
CY2023Q3 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
26667 usd
us-gaap Administrative Fees Expense
AdministrativeFeesExpense
26667 usd
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2266500 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2266500 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2266500 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2266500 shares
CY2024Q3 BOWN Ordinary Shares Subject To Redemption
OrdinarySharesSubjectToRedemption
6900000 shares
CY2023Q4 BOWN Ordinary Shares Subject To Redemption
OrdinarySharesSubjectToRedemption
6900000 shares
us-gaap Common Stock Voting Rights
CommonStockVotingRights
each holder of a right will automatically receive one-tenth (1/10) of one ordinary share upon consummation of the initial Business Combination
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001493152-24-045956-index-headers.html Edgar Link pending
0001493152-24-045956-index.html Edgar Link pending
0001493152-24-045956.txt Edgar Link pending
0001493152-24-045956-xbrl.zip Edgar Link pending
bown-20240930.xsd Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
bown-20240930_def.xml Edgar Link unprocessable
bown-20240930_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
bown-20240930_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
Show.js Edgar Link pending
bown-20240930_cal.xml Edgar Link unprocessable